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IgA plasma cells in the intestinal lamina propria are derived largely from 
precursors in Peyer's patches (1). Absorption of antigen and its interaction with 
Peyer's patch  lymphoid tissue  are  probably  the  initial  events  leading to  a 
mucosal IgA response. Induction of a local IgA response to an orally adminis- 
tered soluble protein in unsensitized animals has usually required prolonged 
feeding of large amounts of antigen (2, 3). Conditions which might improve the 
antigenicity of proteins at mucosal surfaces have not been described. In specific, 
variations in antigen form or function which might enhance either its absorp- 
tion or its interaction with lymphoid cells have not been studied. Definition of 
features which improve the immunogenicity of locally applied antigens would 
give insight into the mechanisms of antigen processing by intestinal lymphoid 
tissue,  permit  the  design of more detailed studies  of the  mucosal immune 
system, and guide the development of materials for oral immunization. 
This report describes quantitative studies of the mucosal antitoxin response 
in rats  after  enteric administration of different forms of cholera toxin  and 
toxoid, protein antigens which differ primarily in their ability to bind to cell 
membranes  and  to  activate  membrane-bound  adenyl  cyclase.  The  results 
suggest that these two features markedly affect the ability of these antigens to 
induce primary or secondary type responses in the intestinal immune system 
when given locally. Crude antigen preparations  are also shown to be more 
effective as mucosal immunogens than are purified materials. Simple, two-dose 
regimens  of local  antigen  which provoke  a  mucosal  immune  response  are 
demonstrated,  and  immunologic memory induced by  a  single  local dose  of 
antigen is described. 
Materials and Methods 
Rats.  Rats  were  females  of the  inbred  Wistar-Lewis  strain  supplied  by  Charles  River 
Breeding Laboratories  (Wilmington,  Mass.),  and  they  were housed  in  a  conventional rodent 
colony. 
Toxin and Toxoid Preparations.  Purified cholera toxin (choleragen) was NIH lot 1071, made 
by  Finkelstein  and  LoSpalutto  (4). Crude  cholera  toxin  was  NIH  lot  001, made  by  Wyeth 
Laboratories, Marietta, Pa. according to the method of Craig (5), except that it was not dialyzed 
before lyophilization. Both were provided by Dr. C. E. Miller, National Institute of Allergy and 
* Supported by research grant AI-07625 from the National Institute of Allergy and Infectious 
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TABLE  I 
Comparison of Toxin and Toxoid Preparations 
Preparation  BDJmg*  Lf/mg$  BD4/Lf§ 
Purified toxin  8.5 ×  107  1,039  8.2  ×  104 
Crude toxin  3.2 ×  103  -  - 
Purified B subunit  2.1  ×  103  1,631  1.3 
Purified toxoid  1.8  ×  102  450  0.4 
Crude toxoid  0.8 ×  103  21  38 
* A  measure of toxic activity. One BD4 is the amount of material which produces a  blue 
lesion with a diameter of 4 mm after intradermal injection in rabbits.  The lesion size is 
measured 22-24 h after injection and 1 h after intravenous administration of Pontamine 
Sky Blue dye.  Assays were performed by Dr.  J.  P.  Craig,  Downstate  Medical Center, 
Brooklyn, N. Y. (6, 7). 
$ Lf units are a  measure of B subunit content of the material based on flocculation with 
antibody to B subunit. These were determined by Dr. R. O. Thomson, Wellcome Research 
Laboratories (for purified toxoid and crude toxoid), or Dr. R. A. Finkelstein (for purified 
toxin and  B  subunit,  from ref.  8).  The assay method and unitage of a  standard  equine 
anti-B subunit serum have been described elsewhere (8). 
§ Toxic activity relative to content of B subunit antigen. 
Infectious Diseases, Bethesda, Md. Purified B subunit of cholera toxin (choleragenoid, lot GB76) 
was a  gift of Dr. Finkelstein,  University of Texas, Southwestern Medical School, Dallas, Texas 
(4).  Purified cholera toxoid and  crude toxoid were prepared  by Dr.  R.  O.  Thomson,  Wellcome 
Research Laboratories,  Beckenham,  England.  Purified toxoid was lot Px377c,  inactivated with 
formalin and immunopurified as previously described (3).  Crude toxoid was lot VT2177c.  It was 
prepared from a formalin-treated culture filtrate of Vibrio cholerae, Inaba 569B,  by precipitation 
with ammonium sulfate (50 kg per 100 liters), dialysis against water, reprecipitation with 2.1  M 
potassium phosphate pH 8.0,  dialysis against water, and lyophilization. The toxic activity and B 
subunit  content  of these  preparations  are  summarized  in  Table  I.  Residual  toxic  activity in 
purified toxoid was negligible (0.0005% of purified toxin, based on BDJLf). It was only threefold 
greater in purified B subunit  (0.0016%),  but was 100-fold greater in crude toxoid (0.05%). 
Immunization.  Toxin or toxoid preparations  were given intraduedenally  (i.d.) 1 or intragas- 
trically  (i.g.).  For i.d.  immunization,  purified antigens were given in 0.5 ml of 0.05  M  borate- 
buffered saline with 0.02%  gelatin, pH 7.4; crude antigens were given in 0.5 ml of 0.15 M NaC1. 
Injection was directly into the duodenal lumen as described elsewhere (3). For i.g. immunization, 
crude antigens were dissolved in 0.5 ml of 0.2 M  NaHCO3 and given through  a  thin polyvinyl 
orogastric tube after an overnight fast. None of the immunizing regimens used induced diarrhea. 
Antitoxin-Containing Cells (ACC) in Intestinal Lamina Propria.  The methods used to identify 
and count ACC in small bowel lamina propria were exactly as previously reported (3). In brief, 
pieces of intestine were frozen over liquid nitrogen and 5-~em thick sections were cut on a cryostat 
and fixed in methanol. ACC were identified by an indirect fluorescent antibody technique which 
involved sequential staining of tissue sections with purified toxoid followed by an immunopurified 
fluorescein-conjugated rabbit  antitoxin.  Their appearance  is shown in Fig.  1.  The frequency of 
ACC is expressed as the number per mm  s in the basal region of the lamina propria. 
Comparison of Antigen  Effectiveness for i.d. Priming and Boosting.  Few ACC appeared  in 
intestinal  lamina  propria  after  a  single  i.d.  injection of most  antigens  tested.  Therefore,  the 
efficacy of priming by different antigen forms and doses was judged by measuring the frequency 
of ACC in lamina  propria  5 days  after a  constant  effective i.d.  booster.  Previous studies had 
shown the booster response to be maximal at this interval (3). Similarly, the efficacy of different 
antigen  forms and  doses for i.d.  boosting was judged by measuring the response  5 days after 
boosting of rats given a constant effective i.d. primer. 
Antitoxin Assay.  Serum antitoxin was measured by a neutralization assay using $49-1 mouse 
1Abbreviations used in this paper: ACC, antitoxin-containing cells; FCA, Freund's complete 
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FIG.  1.  Antitoxin-containing  plasma cells in jejunal lamina prepria. A rat was given 40 
mg crude toxoid plus 1.5 mg crude toxin i.d. on day 0, and 40 mg crude toxoid i.d. on day 
113. Jejunal biopsy was on day 118. Several brightly fluorescent plasma cells are seen near 
a tangentially cut crypt. Antitoxin is also visible in the apical portion of crypt epithelial 
cells in a pattern typical of secretory IgA (9). x 640. 
lymphoma cells grown in 96-well tissue culture plates. The technique was that described by Ruch 
et al.  (10), with minor modifications. It is based on evidence that cholera toxin, in picogram 
amounts,  inhibits division of $49-1 lymphoma cells,  and  that  this  effect  is  prevented by 
preincubation of toxin with  antitoxin. All assays  were  performed  in duplicate.  Results are 
expressed  in  antitoxin units/ml determined by  comparison with  a  simultaneously assayed 
standard antitoxin (Swiss Serum and Vaccine Institute, lot EC3 [A-2/67]-B, 4470 U/ml) provided 
by Dr. C. E. Miller. 
Statistics.  Statistical analysis was by Student's t test applied to the difference in geometric 
mean responses. 
Results 
i.d. Priming of the Mucosal Immune Response 
DOSE-RESPONSE TO DIFFERENT FORMS OF TOXIN AND TOXOID.  When rats were 
given 1 mg of purified toxoid i.d. followed in 14 days by 40 mg of crude toxoid by 
the same route, no ACC were seen in jejunal lamina propria examined 5 days 198  ANTIGEN  FORM  AND  THE  INTESTINAL  IMMUNE  RESPONSE 
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FIG.  2.  Dose-response  to  i.d.  priming with purified toxin,  B  subunit,  or crude cholera 
toxoid plus crude toxin.  Priming (i.d.) was on day 0, boosting was on day 14 with 40 mg 
crude toxoid; jejunal biopsies were taken 5 days later. Each point is the geometric mean of 
data from at least eight rats.  The dose of purified toxoid is given in  /~g.  The dose of B 
subunit  is the molar  equivalent of the toxin  dose,  e.g.  8.3  ~  B  subunit is the molar 
equivalent of 12.5 p,g toxin. The dose of crude toxoid plus crude toxin was plotted according 
to its total content of active toxin. Three doses of crude toxoid were used 8, 19, and 40 mg, 
each with the addition of 1.5 mg crude toxin. 
later. In contrast, initial i.d. doses of purified toxin, purified B subunit, or crude 
toxoid combined with crude  toxin gave evidence of local priming  which was 
dose-dependent.  This  was  easily  seen  by  examining  the  response  after  a 
constant i.d. booster dose of crude toxoid (Fig.  2). Unboosted rats examined at 
the  same  interval  afar  priming  with  these  materials  (day  19)  had  mean 
responses which were only 2-17% as large,  and unprimed rats examined 5 days 
after this booster dose had no detectable response (Table II). On a molar basis, 
purified  toxin  was  about  10-fold more  effective than  its  B  subunit,  priming 
being detected with as little as 100 ng of toxin. When compared with respect to 
its toxin content,  crude toxoid combined with crude toxin was more effective 
than purified toxin and gave a steeper dose-response curve (Fig. 2). 
MUCOSAL PRIMING WITH TOXOID-TOXIN COMBINATIONS.  In  the  comparison 
above, crude toxoid was combined with crude toxin for local priming because 
the combination was more effective than the individual components. Evidence 
of this enhancement is summarized in Table III. The priming efficacy of 40 mg 
of crude toxoid was enhanced five to sevenfold by the addition of 1.5 mg crude 
toxin (P <  0.01).  The response to this combination was greater than the sum of 
the  separate  priming  effects  of  these  materials;  combining  an  equivalent 
amount of purified toxin (150 ng) with crude toxoid was equally effective (P < 
0.05).  In contrast,  addition of an equimolar amount of purified B  subunit  (100 
ng) had no enhancing effect. 
These results suggested that toxin enhanced the priming efficacy of toxoid, or 
vice versa.  This possibility was studied using combinations of purified toxoid 
and purified toxin for i.d.  priming.  The results,  shown in Fig.  3,  demonstrate NATHANIEL  F.  PIERCE  199 
TABLE II 
Immune Response in Rat Jejunum after Local Exposure to Cholera Toxoid and/or 
Toxin 
i.d. Immunization,  day 0 
ACC  Frequency in  jejunal lamina propria* 
Day 19 not  Day 19 boosted,  Day 5  boosted  day 145 
Crude toxoid  (40 mg) and crude  156  231  9,900 
toxin (1.5 mg)  (117-207)  (138-381)  (7,560-12,950) 
Purified toxin (12.5 ~g)  115  700  13,100 
-  (466-1,051)  (11,120-15,430) 
Purified B subunit (8.3 ~g)  144  162  935 
(132-158)  (130-199)  (541-1,620) 
Purified toxoid (1 mg)  115  115  115 
Crude toxoid (40 mg)  115  NT  NT 
* ACC  × mm -3 in jejunal lamina propria 5 or 19 days after i.d.  injection of  the indicated 
material; a single injection  was given unless stated otherwise; geometric mean and range 
of  -+ SE. Each mean was derived from 5 to 16 rats.  For calculation of  means, biopsies with 
no detectable ACC  were given a value of  115  x  mm -3. 
5 Booster dose was 40 rng crude toxoid, i.d. 
NT, not tested. 
TABLE HI 
Effect of Added Toxin or B Subunit on Mucosal Priming by Crude Cholera 
Toxoid 
Primary i.d. immunization 
Number  ACC  Frequency inje- 
of rats  junal lamina propria  P$ 
after i.d. boosting* 
Crude toxoid alone (40 mg)  9  1,500 
(800-2,800) 
plus crude toxin (1.5 mg)  11  9,900  <0.01 
(7,600-12,900) 
plus purified toxin (150 ng)  9  7,400  <0.05 
(5,400-10,400) 
plus purified B subunit (100  13  2,700  NS§ 
ng)  (1,700-4,300) 
Crude toxin alone (1.5 mg)  5  409  NS 
(339-496) 
* i.d. boosting was with 40 mg crude toxoid on day 14. Jejunal biopsies were taken 5 
days later. ACC frequency is given as geometric mean ACC  ×  mm  -~ and range 
of -+ SE. 
$ Versus results in rats primed with crude toxoid alone. 
§ NS, not significant. 
that  varying amounts  of purified toxin combined with  1-mg doses of purified 
toxoid were no more effective as local primers than were the doses of purified 
toxin given alone. 
Boosting (i.d.) after Local Priming 
DOSE-RESPONSE  TO DIFFERENT FORMS OF TOXIN AND TOXOID.  After i.d. prim- 
ing with an effective dose  of purified toxin  (12.5  fig),  booster responses were 200  ANTIGEN  FORM  AND  THE  INTESTINAL  IMMUNE  RESPONSE 
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FIG.  3.  Dose-response to i.d. priming with purified toxin with or without the addition of 
purified toxoid.  Rats were primed i.d. with purified toxin with or without 1 mg purified 
toxoid on day 0. Boosting was with 40 mg crude toxoid i.d. on day 14 and jejunal biopsies 
were obtained 5 days later. Each point is the geometric mean of data from 8 rats. ©, primed 
with toxin only; O, primed with toxin plus 1 mg pure toxoid. 
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Fro.  4.  Dose-response to i.d. boosting with purified toxin, B subunit,  or purified toxoid. 
Rats were primed i.d. with 12.5  ~g purified toxin on day 0. Boosting (i.d.) was on day 14 
and jejunal biopsies were obtained 5 days later. Each point is the geometric mean of data 
from eight rats. The hatched bar is range of mean _SE from jejunal biopsies taken 19 days 
after i.d. priming, no booster given. 
elicited  by  i.d.  doses  of purified  toxin  or  B  subunit  (Fig.  4).  Their  relative 
effectiveness for i.d. boosting was similar to that seen for priming, toxin again 
being about 10-fold more effective on a molar basis. In contrast, purified toxoid, 
which was ineffective  as an i.d.  primer in a  dose of 1 mg, was an effective i.d. 
booster; a significant booster effect was seen with a dose as low as 40 ~4g. None 
of these materials induced appreciable responses after 5 days in unprimed rats 
(Table II). 
Duration of  Local Memory After i.d. Priming.  The duration of local memory 
was determined  by giving an i.d.  booster of crude toxoid at varying intervals 
after i.d.  priming with crude toxoid plus crude toxin,  and counting the jejunal 
ACC which appeared after boosting. Maximum booster responses were not seen 
until 2 wk after i.d. priming, and they were of similar size with booster intervals NATHANIEL  F.  PIERCE  201 
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FIG.  5.  Duration of local memory after i.d.  priming.  Rats were primed i.d.  with 40 mg 
crude texoid plus 1.5 mg crude toxin on day 0. Boosting was with 40 mg crude texoid i.d. at 
the indicated interval. Each point is the geometric mean of data from at least eight rats. 
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Fro.  6.  Relation of mucosal and systemic antitoxin responses after local immunization. 
Rats were primed i.g. with 40 mg crude toxoid plus 1.5 mg crude toxin (@), or with 12.5/zg 
purified toxin (O). Boosting was on day 14 with 40 mg crude texoid i.g. Jejunal biopsy for 
ACC frequency, and serum for antitoxin titer, were obtained 5 days later. 
of as long as 16 wk.  With a  booster interval of 32 wk, a  diminished and more 
variable booster response was seen (Fig. 5). 
Relation of Mucosal and Systemic Antitoxin Responses After Local Immuni- 
zation.  Oral  or  i.d.  immunization  induced  modest  but  detectable antitoxin 
responses in serum. For example, in nonimmunized rats, the serum titer was 15 
_+ 1 U/ml (geometric mean  _+ standard error), whereas rats given crude toxoid 
(40  mg) plus crude toxin  (1.5 mg) by mouth,  followed in  14 days with crude 
toxoid by mouth (40 mg) had titers of 63 _  9 and 51 _+ 8 U/ml on days 14 and 19, 
respectively. There was, however, no correlation between serum antitoxin titers 
and the frequency of ACC in jejunal lamina prepria of individual rats 5 days 
after local boosting. This includes rats immunized as above or primed i.g. with 202  ANTIGEN  FORM  AND  THE  INTESTINAL  IMMUNE  RESPONSE 
TABLE IV 
Comparison of Mucosal and Systemic Antitoxin Responses after Local 
Immunization with Purified Cholera Toxoid 
Serum antitoxin U/  ACC in jejunal lam- 
ml, mean __- SE*  ina propria* 
1.  Immunized 
I  mg pure texoid  63 -  22  None seen 
i.d., days 0 and 14  n  =  5  n  =  15 
2.  Not immunized  15  +-- 1  None seen 
n  =  28  n  =  10 
P  <  0.001 
* Determined 5 days after i.d. boosting. 
purified toxin and boosted as above (Fig.  6).  In addition, rats given two i.d. 
doses of purified toxoid (1 mg each) developed a significant fourfold elevation in 
serum antitoxin (P <  0.001) with no detectable ACC in jejunal lamina propria 
(Table IV). 
Discussion 
We have previously described an IgA antitoxic response in the intestinal 
mucosa of rats given purified toxoid by a parenteral-intestinal sequence or fed 
crude texoid for a prolonged period (3). The present study shows that a vigorous 
mucosal antitoxin response can also be induced in rat intestine by a simple two- 
dose local immunizing regimen, provided that the initial dose contains either 
active holotoxin or its B subunit. The first and second doses appear to induce 
local primary and secondary type responses, respectively. As discussed below, 
the marked differences in the effectiveness of cholera toxin, its B subunit, or 
cholera toxoid as local antigens appear to result from established differences in 
the properties of these proteins. While all three are antigenic, sharing the major 
B subunit antigen of cholera toxin, only cholera toxin and the B subunit bind 
avidly to ubiquitous GM1  ganglioside receptors on cell membranes (11), and 
only the holotoxin activates membrane-bound adenyl cyclase (12). 
Purified toxoid was ineffective as a local primary antigen, which agrees with 
our  earlier  studies  in  rats  and  dogs  (3,  13). This  was  not  simply  due  to 
destruction of antigenicity during toxoiding, since the same material primed 
the mucosal immune system in rats when given i.p.  with (Freund's complete 
adjuvant (FCA)  (3) and in dogs when given subcutaneously (13), and was also 
effective as a local booster in previously primed rats and dogs (3, 13). Nor was 
this failure due to the lack of absorption of the toxoid since repeated local doses 
provoked a  systemic antitoxin response. Possibly, purified toxoid was a  poor 
local primer because it could not bind to ganglioside receptors on the membranes 
of Peye~s patch cells and was thus poorly "trapped". Ferritin, another nonad- 
herent protein (14), is also a poor mucosal antigen in unprimed mice; prolonged 
feeding of large amounts is needed to induce a  local IgA response  (2). Poor 
antigen trapping in unprimed animals may reflect a paucity of macrophages in 
Peyer's patches,  which has  been demonstrated in  mice  (15). The idea that 
membrane-binding  facilitates local priming is supported by the observed greater NATHANIEL  F.  PIERCE  203 
priming efficacy of the B subunit which binds avidly to GM1 ganglioside in cell 
membranes. On the other hand,  this property of membrane adherence by a 
nonimmune mechanism may give less advantage in local boosting of previously 
primed animals. This is suggested by the much better performance of purified 
toxoid as a local booster which may reflect an enhanced ability to bind absorbed 
antigen to antibody-like surface receptors on an expanded population of sensi- 
tized lymphocytes in Peyer's patches. 
Cholera toxin was the most effective purified antigen studied, being about 10- 
fold more effective on a molar basis than its B subunit, both as a local primer 
and booster. This difference was not likely the result of increased absorption of 
toxin from the intestinal lumen or its increased trapping in Peyer's patches, 
since these antigens have similar membrane-binding properties. Cholera toxin, 
however, also activates membrane-bound adenyl cyclase, thus increasing intra- 
cellular levels of cAMP (16). Agents which increase cAMP levels in lympho- 
cytes, as cholera toxin does (17, 18), have marked effects upon a wide variety of 
lymphocyte-mediated activities (19), including antibody production (20). Chol- 
era  toxin  has  already  been  shown to  both  enhance and  suppress  systemic 
antibody production when given parenterally, the effect depending upon dose 
and time of administration in relation to specific immunization (18, 21). These 
actions are thought to be mediated by its effect upon levels of cAMP in lymphoid 
cells (18). It is likely that the greater efficacy of cholera toxin than B subunit 
both as a  local primer and booster also reflects this pharmacologic effect on 
lymphocyte  (or  macrophage)  function.  Thus  cholera  toxin  may  be  a  self- 
adjuvanting molecule possessing two features, membrane-binding and adenyl 
cyclase activation, which markedly enhance its effect as a local immunogen. 
A crude cholera toxoid with residual toxin also gave local priming, and its 
effectiveness was increased five to sevenfold by the addition of small amounts of 
crude  or  purified toxin,  but  not by  equimolar  amounts of B  subunit.  The 
combination of crude toxoid with residual and added toxin gave a greater local 
priming than could be explained by its content of toxin alone or by the sum of 
the separate effects of the crude toxoid and the added crude toxin. These results 
suggest that the local priming effect of toxin is enhanced by other components 
of crude toxoid or, conversely, that holotoxin enhances the responses to toxoid 
forms in the crude toxoid. In either case, the role of holotoxin appears largely 
dependent upon its ability to activate adenyl cyclase rather than its membrane- 
binding property, since purified B subunit was ineffective. The simple possibil- 
ity that toxin and toxoid act in a synergistic manner appears unlikely, however, 
since this could not be shown with combinations of purified toxoid and toxin. It 
is possible that other materials or antigen forms in crude toxoid account for its 
enhanced activity when combined with active toxin. 
The duration of local immunologic  memory was studied in rats given a single 
i.d. dose of crude toxoid plus crude toxin. The results differed appreciably from 
those previously reported for rats primed with purified toxoid plus FCA i.p. (3). 
Local memory after i.d. priming was undiminished for 4 mo and only modestly 
diminished at 8 mo. In contrast, local memory present 2 wk after i.p. priming 
was reduced by 70% when the booster interval was extended to 3 mo (3). We 
have now shown that this decline in memory is due to the emergence of antigen- 204  ANTIGEN  FORM  AND  THE  INTESTINAL  IMMUNE  RESPONSE 
specific suppression of the local immune response as the dominant effect of i.p. 
immunization (N. F. Pierce, unpublished observations); the mechanism of this 
suppression is being studied. Irrespective of the mechanism, the present study 
shows that  local memory can  last  longer than previously reported, possibly 
because the local primer used was less effective in provoking a late suppressive 
effect. 
Results of this study are  of potential importance in the development and 
evaluation of effective oral vaccines.  They show that a  simple two-dose oral 
regimen  using  a  soluble  protein  can  induce  a  vigorous  mucosal  immune 
response in the small bowel. They also emphasize the difficulty in local priming 
of the mucosal immune system and suggest two specific properties for antigens, 
membrane-binding, and adenyl cyclase activation, which may enhance their 
performance as local immunogens raising the possibility that proteins for oral 
immunization should be selected for, or modified to have, one or both of these 
properties. The lack of correlation of systemic and mucosal immune responses 
in individual animals emphasizes the compartmentalization of the systemic and 
mucosal immune systems and the practical difficulties in assessing the local 
response to oral antigens, especially in humans in whom access to intestinal 
tissue or fluid is limited. And finally, although the role of immunologic  memory 
in  defense of the  intestine by  the  IgA  system is  uncertain,  its  presence is 
confirmed  and  it  is  shown  to  be  relatively  prolonged after  effective  local 
priming. 
Summary 
This report describes studies of the mucosal antitoxic response in rats after 
enteric  administration of several  forms  of cholera  toxin or  toxoid,  proteins 
which differ primarily in their ability to bind to cell membranes and activate 
cellular adenyl cyclase.  These two characteristics appeared to  markedly en- 
hance the local primary response to these antigens.  A  single dose of toxoid 
lacking these features was  ineffective in  local priming even though it was 
absorbed and induced a systemic immune response. Single dose mucosal prim- 
ing occurred only with preparations which bind to cell membranes and was 
enhanced by those which also  activate  cellular  adenyl cyclase.  In contrast, 
single-dose mucosal boosting was best accomplished by materials with these 
properties but was also seen with a toxoid lacking both of these functions. The 
property of membrane binding appears to be most advantageous in mucosal 
priming,  perhaps  by  increasing  effective  trapping  of absorbed  antigen  in 
unprimed mucosal  lymphoid tissue,  whereas  the  ability  to  activate  adenyl 
cyclase  appears  to  enhance  primary  and  secondary  type  responses  about 
equally.  Combinations of crude toxoid and toxin were also more effective in 
mucosal priming than purified materials,  a  finding which is unexplained. A 
single  dose  of this  combination  induced mucosal  priming which was  fully 
developed in 2 wk, undiminished after 4 too, and only modestly diminished after 
8  mo,  thus demonstrating relatively prolonged memory in the IgA mucosal 
immune system. Effective two-dose local immunizing regimens were developed, 
and  it  was  shown that  there was  no correlation between the  mucosal and 
systemic secondary antitoxin responses provoked by these regimens. NATHANIEL  F.  PIERCE  205 
Excellent technical assistance was given by William C. Cray, Jr.,  Pamela F. Engel, and Patricia 
P. Scribner. We thank Dr. R. A. Finkelstein for  the gift  of  purified  B subunit, Dr. R. O. Thomson 
for the crude and purified  cholera toxoid,  and Dr. J. P. Craig for  performance of  the BD4 assays. 
Acknowledgement  is  made of  research facilities  provided by the Gerontology Research Center of 
the National Institute  of  Aging under its  Guest Scientist  program. 
Received for publication 20 March 1978. 
References 
1.  Craig, S. W., and J. J. Cebra. 1971. Peyer's patches: an enriched source of precursors 
for IgA-producing immunocytes in the rabbit. J. Exp. Med. 134:18. 
2.  Crabbe,  P.  A.,  D.  P.  Nash,  H.  Bazin,  H.  Eyssen,  and  J.  F.  Heremans.  1969. 
Antibodies of the IgA type in intestinal plasma cells of germ free mice after oral or 
parenteral immunization with ferritin. J. Exp. Med. 130:723. 
3.  Pierce, N.  F., and J.  L. Gowans.  1975. Cellular kinetics of the intestinal immune 
response to cholera toxoid in rats. J. Exp. Med. 142:1550. 
4.  Finkelstein, R. A., and J. J. LoSpalutto. 1969. Pathogenesis of experimental cholera: 
preparation and isolation of choleragen and choleragenoid. J. Exp. Med. 130:185. 
5.  Craig, J. P. 1966. Preparation of a vascular permeability factor of Vibrio cholerae. J. 
Bacteriol.  92:793. 
6.  Craig, J. P. 1971. Cholera toxins. In Microbial Toxins. S. Kadis, T. C. Montie and S. 
J. Ajl, editors. Academic Press, Inc., New York. ZA:189. 
7.  Craig,  J.  P.  1970. Some  observations  on  the  neutralization  of cholera vascular 
permeability factors in vivo. J. Infect. Dis. 121 (Suppl.):S100. 
8.  Finkelstein, R. A.  1970. Monospecific equine antiserum against cholera exo-entero- 
toxin. Infect. Immun. 2:691. 
9.  Brandtzaeg, P. 1974. Mucosal and glandular distribution of immunoglobulin compo- 
nents:  immunochemistry  with  a  cold  ethanol-fixation  technique.  Immunology. 
26:1101. 
10.  Ruch,  F.  E., J.  R.  Murphy, L.  H.  Graf, and M.  Field.  1978. The isolation of non- 
toxigenic mutants of Vibrio cholerae using a colorimetric $49 lymphocarcinoma cell 
assay for cholera toxin. J. Infect. Dis. In press. 
11.  Cuatrecasas,  P.  1973. Vibrio cholerae  choleragenoid.  Mechanism of inhibition of 
cholera toxin action. Biochemistry. 12:3577. 
12.  Flores, J., P. Witkum, and G. W. G. Sharp. 1976. Activation of adenylate cyclase by 
cholera toxin in rat liver homogenates. J. Clin. Invest. 57:450. 
13.  Pierce, N. F., W. C. Cray, and B. K. Sircar. 1978. Induction of a mucosal antitoxin 
response and its role in immunity to experimental canine cholera. Infect. Immun. In 
press. 
14.  Bockman,  D.  E.,  and  W.  B.  Winborn.  1966. Light  and  electron  microscopy of 
intestinal ferritin absorption. Observations in sensitized and nonsensitized hamsters 
(Mesocricetus auratus). Anat. Rec. 155:603. 
15.  Kagnoff, M. F., and S.  Campbell. 1974. Functional characteristics of Peyer's patch 
lymphoid cells. I. Induction of humoral antibody and cell-mediated allograft reac- 
tions. J. Exp. Med. 139:398. 
16.  Kimberg,  D.  V.,  M.  Field,  J.  Johnson,  A.  Henderson,  and  E.  Gershon.  1971. 
Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prosta- 
glandins. J. Clin. Invest. 50:1218. 
17.  Mozes, E., Y. Weinstein, H. R. Bourne, K. L. Melmon, and G. M. Shearer. 1974. In 
vitro correction of antigen-induced immune suppression: effects of histamine, dibu- 
tyryl cyclic AMP and cholera enterotoxin. Cell. Immunol. 11:57. 
18.  Holmgren, J., and L. Lindholm. 1976. Cholera toxin, ganglioside receptors and the 206  ANTIGEN  FORM  AND  THE  INTESTINAL  IMMUNE  RESPONSE 
immune response. Imraunol. Commun. 5:737. 
19.  Braun, W. B., L. M. Lichtenstein, and C. W. Parker, editors. 1974. Cyclic AMP, Cell 
Growth, and the Immune Response. Springer-Verlag, New York. 416. 
20.  Ishizuka,  M.,  W.  Braun,  and  T.  Matsumoto.  1971. Cyclic  AMP  and  immune 
responses.  I. Influence of poly A:U and cAMP on antibody formation in  vitro.  J. 
Immunol.  107:1027. 
21.  Northrup, R. S., and A. S. Fauci. 1972. Adjuvant effect of cholera enterotoxin on the 
immune response of the mouse to sheep red blood cells. J. Infect. Dis.  125:672. 